This company has been marked as potentially delisted and may not be actively trading. Symmetry Medical (SMA) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsCompetitorsEarningsInsider TradesTrendsBuy This Stock Get the Latest News and Ratings for SMA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Symmetry Medical and its competitors. Enter your email to sign up for newsletter Sign Up SMA Analyst Ratings Over TimeTypeCurrent Forecast5/18/24 to 5/18/251 Month Ago4/18/24 to 4/18/253 Months Ago2/18/24 to 2/17/251 Year Ago5/19/23 to 5/18/24Strong Buy3 Strong Buy rating(s) N/A N/A N/A Buy9 Buy rating(s) N/A N/A N/A Hold0 Hold rating(s) N/A N/A N/A Sell0 Sell rating(s) N/A N/A N/A Consensus Price Target$38.50N/AN/AN/AForecasted Upside4.17% UpsideN/AN/AN/AConsensus RatingBuyN/AN/AN/A SMA Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History SMA Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Symmetry Medical Stock vs. The CompetitionTypeSymmetry Medical CompaniesS&P 500Consensus Rating Score 3.25 3.13 2.54Consensus RatingBuyBuyModerate BuyPredicted Upside4.17% Upside614.15% Upside12.57% UpsideNews Sentiment RatingNeutral NewsSee Recent SMA NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails5/15/2025Robert W. Baird2 of 5 starsWesley GolladaySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetOutperform ➝ Outperform$38.00 ➝ $40.00+11.30%4/29/2025National Bankshares2 of 5 stars Set TargetOutperform$39.00+14.71%4/28/2025National Bank Financial5 of 5 starsM. KornackSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/28/2025Baird R WSubscribe to MarketBeat All Access for the recommendation accuracy ratingW. GolladaySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/28/2025ScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingD. TricaricoSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageSector Outperform$36.00+7.62%4/28/2025Wells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingEric LuebchowSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$38.00+13.60%4/28/2025Raymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingJ. HughesSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$40.00+19.58%4/28/2025BMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingJ. SanabriaSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$40.00+19.58%4/28/2025Truist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingKi Bin KimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$38.00+13.60%4/28/2025Stifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingSimon YarmakSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$40.00+19.58%4/28/2025JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingMichael MuellerSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$36.00+7.62%4/28/2025KeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingTodd ThomasSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$38.00+13.60%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 08:59 AM ET. SMA Forecast - Frequently Asked Questions What is Symmetry Medical's forecast for 2025? According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Symmetry Medical is $38.50, with a high forecast of $40.00 and a low forecast of $36.00. Should I buy or sell Symmetry Medical stock right now? 12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Symmetry Medical in the last twelve months. There are currently 9 buy ratings and 3 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SMA shares. Does Symmetry Medical's stock price have much upside? According to analysts, Symmetry Medical's stock has a predicted upside of 4.17% based on their 12-month stock forecasts. Has Symmetry Medical been upgraded by Wall Street analysts recently? Over the previous 90 days, Symmetry Medical's stock had 3 upgrades by analysts. What analysts cover Symmetry Medical? Symmetry Medical has been rated by research analysts at Baird R W, BMO Capital Markets, JPMorgan Chase & Co., KeyCorp, National Bank Financial, National Bankshares, Raymond James, Robert W. Baird, Scotiabank, Stifel Nicolaus, Truist Financial, and Wells Fargo & Company in the past 90 days. Do Wall Street analysts like Symmetry Medical more than its competitors? Analysts like Symmetry Medical more than other "" companies. The consensus rating score for Symmetry Medical is 3.25 while the average consensus rating score for "" companies is 3.13. Learn more on how SMA compares to other companies. Stock Forecasts and Research Tools Related Companies ABT Stock Forecast ISRG Stock Forecast BSX Stock Forecast SYK Stock Forecast MDT Stock Forecast BDX Stock Forecast EW Stock Forecast IDXX Stock Forecast RMD Stock Forecast DXCM Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NYSE:SMA) was last updated on 5/18/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowMusk has launched a bold new AI initiative—and while you can’t invest in it directly, one overlooked stock cou...Behind the Markets | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Two drop-dead simple ways to play the gold boomIf you take a few minutes to check out the short research briefing Mark & I have put together, I’m confident y...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Symmetry Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Symmetry Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SMA Stock Free SMA Stock Alerts